4-ANZCA-submission-Therapeutic-Products-Regulatory-Scheme
PS12(PM)BP Position Statement on the use of ketamine in the management of CNCP Background paper
Justification for the statement from the Faculty of Pain Medicine on the use of ketamine with reference to its use in the management of patients with chronic non-cancer pain.
ANZCA Bulletin December 2018
ANZCA Annual Report 2023
Read the Australian and New Zealand College of Anaesthetists (ANZCA) annual report for 2023.
ANZCA-statement-on-climate-change_2020
Marriage-equality-statement-rebranded
101221-Protected-title-media-statement
Marriage equality statement
Archived- Marriage Equality Statement
ANZCA statement on desflurane 2024
ANZCA statement on desflurane 2024
ANZCA Gender equity statement
Read our gender equity statement